Holly A Earls1, Tim Curran1, Vijay Mittal2,3. 1. Department of Psychology and Neuroscience, Center for Neuroscience, University of Colorado Boulder, Boulder, CO. 2. Department of Psychology, Northwestern University, Evanston, IL. 3. Department of Psychiatry, Northwestern University, Chicago, IL.
Abstract
INTRODUCTION: As endophenotypes bridge the gap between genetics and phenotypic disease expression, identifying reliable markers is important for fostering understanding of pathophysiology. The present aim was to conduct current meta-analyses of 3 key auditory event-related potential (ERP) components that have been held as potential endophenotypes for schizophrenia: P50, P300 amplitude and latency, and mismatch negativity (MMN), reflective of sensory gating, attention and classification speed, and perceptual discrimination ability, respectively. In order to assess endophenotype viability, these components were examined in unaffected relatives of patients with schizophrenia and healthy controls. METHODS: Effect sizes (ES) were examined between relatives and controls for P50 suppression (10 studies, n = 360 relatives, 473 controls), P300 amplitude (20 studies, n = 868 relatives, 961 controls), P300 latency (17 studies, n = 674 relatives, 792 controls), and MMN (11 studies, n = 377 relatives, 552 controls). RESULTS: Reliable differences in P50 suppression (ES = 0.86, P < .001), P300 amplitude (ES = -0.52, P < .001), and P300 latency (ES = 0.44, P < .05) were found between unaffected relatives and controls. A trend was found between relatives and controls for MMN (ES = 0.21, P = 0.06), and the use of extraneous channels was found to be a significant moderator (P = 0.01). When MMN was analyzed using frontocentral channel Fz, a significant difference was found (ES = 0.26, P < 0.01). DISCUSSION: The results indicate that P50 suppression, P300 amplitude and P300 latency, and MMN may serve as viable endophenotypes for schizophrenia.
INTRODUCTION: As endophenotypes bridge the gap between genetics and phenotypic disease expression, identifying reliable markers is important for fostering understanding of pathophysiology. The present aim was to conduct current meta-analyses of 3 key auditory event-related potential (ERP) components that have been held as potential endophenotypes for schizophrenia: P50, P300 amplitude and latency, and mismatch negativity (MMN), reflective of sensory gating, attention and classification speed, and perceptual discrimination ability, respectively. In order to assess endophenotype viability, these components were examined in unaffected relatives of patients with schizophrenia and healthy controls. METHODS: Effect sizes (ES) were examined between relatives and controls for P50 suppression (10 studies, n = 360 relatives, 473 controls), P300 amplitude (20 studies, n = 868 relatives, 961 controls), P300 latency (17 studies, n = 674 relatives, 792 controls), and MMN (11 studies, n = 377 relatives, 552 controls). RESULTS: Reliable differences in P50 suppression (ES = 0.86, P < .001), P300 amplitude (ES = -0.52, P < .001), and P300 latency (ES = 0.44, P < .05) were found between unaffected relatives and controls. A trend was found between relatives and controls for MMN (ES = 0.21, P = 0.06), and the use of extraneous channels was found to be a significant moderator (P = 0.01). When MMN was analyzed using frontocentral channel Fz, a significant difference was found (ES = 0.26, P < 0.01). DISCUSSION: The results indicate that P50 suppression, P300 amplitude and P300 latency, and MMN may serve as viable endophenotypes for schizophrenia.
Authors: Jyrki Ahveninen; Iiro P Jääskeläinen; Daria Osipova; Matti O Huttunen; Risto J Ilmoniemi; Jaakko Kaprio; Jouko Lönnqvist; Marko Manninen; Satu Pakarinen; Sebastian Therman; Risto Näätänen; Tyrone D Cannon Journal: Biol Psychiatry Date: 2006-07-28 Impact factor: 13.382
Authors: Anna Bravermanová; Michaela Viktorinová; Filip Tylš; Tomáš Novák; Renáta Androvičová; Jakub Korčák; Jiří Horáček; Marie Balíková; Inga Griškova-Bulanova; Dominika Danielová; Přemysl Vlček; Pavel Mohr; Martin Brunovský; Vlastimil Koudelka; Tomáš Páleníček Journal: Psychopharmacology (Berl) Date: 2018-01-05 Impact factor: 4.530
Authors: Holly K Hamilton; Scott W Woods; Brian J Roach; Katiah Llerena; Thomas H McGlashan; Vinod H Srihari; Judith M Ford; Daniel H Mathalon Journal: Schizophr Bull Date: 2019-09-11 Impact factor: 9.306
Authors: Holly K Hamilton; Brian J Roach; Peter M Bachman; Aysenil Belger; Ricardo E Carrion; Erica Duncan; Jason K Johannesen; Gregory A Light; Margaret A Niznikiewicz; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Tyrone D Cannon; Daniel H Mathalon Journal: JAMA Psychiatry Date: 2019-11-01 Impact factor: 21.596
Authors: Kayla R Donaldson; Emmett M Larsen; Katherine Jonas; Sara Tramazzo; Greg Perlman; Dan Foti; Aprajita Mohanty; Roman Kotov Journal: Schizophr Res Date: 2021-10-22 Impact factor: 4.662